Publication: Gametocyte clearance in children, from western Kenya, with uncomplicated Plasmodium falciparum malaria after artemether–lumefantrine or dihydroartemisinin–piperaquine treatment
dc.contributor.author | Muregi, Francis | |
dc.contributor.author | Otinga, Maureen | |
dc.contributor.author | Thiongo, Kelvin | |
dc.contributor.author | Musyoka, Kelvin B. | |
dc.contributor.author | Chege, William | |
dc.contributor.author | Omondi, Protus | |
dc.date.accessioned | 2024-07-24T13:36:56Z | |
dc.date.available | 2024-07-24T13:36:56Z | |
dc.date.issued | 2019-12-04 | |
dc.description.abstract | The efficacy and safety of artemether–lumefantrine (AL) and dihydroartemisinin–piperaquine (DP) against asexual parasites population has been documented. However, the effect of these anti-malarials on sexual parasites is still less clear. Gametocyte clearance following treatment is essential for malaria control and elimination efforts; therefore, the study sought to determine trends in gametocyte clearance after AL or DP treatment in children from a malaria-endemic site in Kenya. Methods Children aged between 0.5 and 12 years from Busia, western Kenya with uncomplicated Plasmodium falciparum malaria were assigned randomly to AL or DP treatment. A total of 334 children were enrolled, and dried blood spot samples were collected for up to 6 weeks after treatment during the peak malaria transmission season in 2016 and preserved. Plasmodium falciparum gametocytes were detected by qRT-PCR and gametocyte prevalence, density and mean duration of gametocyte carriage were determined. Results At baseline, all the 334 children had positive asexual parasites by microscopy, 12% (40/334) had detectable gametocyte by microscopy, and 83.7% (253/302) children had gametocytes by RT-qPCR. Gametocyte prevalence by RT-qPCR decreased from 85.1% (126/148) at day 0 to 7.04% (5/71) at day 42 in AL group and from 82.4% (127/154) at day 0 to 14.5% (11/74) at day 42 in DP group. The average duration of gametocyte carriage as estimated by qRT-PCR was slightly shorter in the AL group (4.5 days) than in the DP group (5.1 days) but not significantly different (p = 0.301). Conclusion The study identifies no significant difference between AL and DP in gametocyte clearance. Gametocytes persisted up to 42 days post treatment in minority of individuals in both treatment arms. A gametocytocidal drug, in combination with artemisinin-based combination therapy, will be useful in blocking malaria transmission more efficiently. | |
dc.identifier.citation | Omondi, P., Burugu, M., Matoke-Muhia, D. et al. Gametocyte clearance in children, from western Kenya, with uncomplicated Plasmodium falciparum malaria after artemether–lumefantrine or dihydroartemisinin–piperaquine treatment. Malar J 18, 398 (2019). https://doi.org/10.1186/s12936-019-3032-3 | |
dc.identifier.uri | https://doi.org/10.1186/s12936-019-3032-3 | |
dc.identifier.uri | https://erepository.mku.ac.ke/handle/123456789/6125 | |
dc.language.iso | en | |
dc.publisher | BMC | |
dc.subject | Artemether–lumefantrine | |
dc.subject | Dihydroartemisinin/piperaquine | |
dc.subject | Plasmodium falciparum gametocyte | |
dc.title | Gametocyte clearance in children, from western Kenya, with uncomplicated Plasmodium falciparum malaria after artemether–lumefantrine or dihydroartemisinin–piperaquine treatment | |
dc.type | Article | |
dspace.entity.type | Publication |